- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 409/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 409/00
Total number of patents in this class: 172
10-year publication summary
|
6
|
2
|
1
|
3
|
2
|
3
|
3
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3717 |
7 |
| Janssen Pharmaceutica N.V. | 3301 |
4 |
| Gilead Sciences, Inc. | 2145 |
4 |
| Theravance Biopharma R&D IP, LLC | 438 |
4 |
| Hoffmann-La Roche Inc. | 3628 |
3 |
| LG Chem, Ltd. | 17759 |
3 |
| Bayer Cropscience AG | 1949 |
3 |
| Abbvie Inc. | 1828 |
3 |
| Northwestern University | 3493 |
3 |
| Bristol-myers Squibb Company | 4792 |
2 |
| Merck Patent GmbH | 5732 |
2 |
| Syngenta Participations AG | 1625 |
2 |
| Allergan, Inc. | 2260 |
2 |
| Centre National de La Recherche Scientifique | 10820 |
2 |
| Sumitomo Chemical Company, Limited | 9058 |
2 |
| Bridge Pharma, Inc. | 31 |
2 |
| Cambridge Display Technology Limited | 487 |
2 |
| Eli Lilly and Company | 3975 |
2 |
| The Hong Kong University of Science and Technology | 795 |
2 |
| Hutchison MediPharma Enterprises Limited | 12 |
2 |
| Other owners | 116 |